Imjudo 25 mg/1.25 mL (20 mg/mL) injection Images

Generic Name: tremelimumab

This medication has been identified as Imjudo 25 mg/1.25 mL (20 mg/mL) injection and is used for Hepatocellular Carcinoma, and Non Small Cell Lung Cancer. It belongs to the drug class anti-CTLA-4 monoclonal antibodies and is not a controlled substance.

Images of medication

Imjudo

Generic Name

tremelimumab

Strength

25 mg/1.25 mL (20 mg/mL) injection

Availability

Prescription only

Drug Class

Anti-CTLA-4 monoclonal antibodies

CSA Schedule

Not a controlled drug

Labeler / Supplier

AstraZeneca

National Drug Code (NDC)

00310-4505

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer